LRN (LRN)
Quantitative Summary
DeterministicFinancial health metrics are strong: Piotroski 7/9, Altman Z 5.6 (above 3.0 safe zone threshold).
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of LRN demonstrate robust capital efficiency, evidenced by an ROIC-WACC spread of 8.0%, indicating the company consistently generates returns significantly above its cost of capital. This profitability is underpinned by a DuPont decomposition where strong gross margins at 39.2% and net margins at 12.0% drive performance, supported by accelerating revenue growth of 17.9%. Financial health metrics further validate this quality profile; the Piotroski F-Score of 7/9 signals high financial strength with minimal deterioration risk, while an Altman Z-Score of 5.6 places the firm well within safe territory regarding bankruptcy probability. Additionally, a Beneish M-Score of -2.66 suggests earnings are unlikely to be subject to manipulation, reinforcing the integrity of these reported fundamentals.
Valuation metrics present a divergence between current market pricing and intrinsic value models. Trading at 13.0x forward earnings, the stock appears compressed relative to its historical trajectory and likely below sector averages given its superior growth rate of nearly 18%. A DCF analysis implies a fair value of $431 per share; if this projection holds based on current cash flow assumptions and implied terminal growth rates, the market price may be pricing in conservative expectations or temporary headwinds rather than structural weakness. The combination of high-quality earnings generation and a valuation multiple that does not fully reflect the 8% excess return spread suggests the asset could offer compelling risk-adjusted upside potential if macro conditions stabilize.
Risk assessment indicators remain benign, with no red flags emerging from the provided data points to suggest elevated downside volatility or governance concerns. The convergence of strong profitability drivers, clean earnings quality signals, and a valuation gap between current prices and DCF estimates creates an asymmetric opportunity profile for long-term holders. However, investors must weigh whether the 13x P/E multiple already incorporates anticipated mean reversion in growth rates before committing capital based solely on these quantitative signals.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 6% | 7.6% | 9.6% |
|---|---|---|---|
| 2% | $516 | $363 | $263 |
| 3% | $669 | $431 | $295 |
| 4% | $977 | $537 | $339 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=7.6%, terminal growth 3%. Fair value $431 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like SLYV or SPSM, the fund manager is mechanically forced to buy or sell LRN shares regardless of LRN's individual fundamentals. We estimate $121M of passive capital is structurally linked to LRN through 6 tracked ETFs. Passive flows have a limited but growing influence on LRN's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 6 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in LRN to visualize passive redemption contagion across ETFs and collateral stocks.
If LRN (LRN) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Amazon.com Inc. (AMZN) as the most exposed collateral stock, sharing 1 ETFs with LRN. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 6 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
LRN Ownership Dynamics
ETFs with Highest LRN Exposure
Float lock-up computed from 7 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
LRN Capital Efficiency
How efficiently does LRN convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
LRN converts 73% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 8.0% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-13 | 10,000 | $87.42 | $874,200 |
| 2026-05-12 | 10,000 | $87.34 | $873,400 |
| 2026-05-06 | 333 | $93.76 | $31,222.08 |
| 2026-05-05 | 554 | $92.26 | $51,112.04 |
| 2026-05-04 | 897 | $93.08 | $83,492.76 |
| 2026-04-29 | 16 | $92.58 | $1,481.28 |
| 2026-04-28 | 136 | $97.79 | $13,299.44 |
| 2026-04-24 | 128 | $98.36 | $12,590.08 |
| 2026-04-22 | 1,499 | $98.11 | $147,066.89 |
| 2026-04-21 | 10 | $98.98 | $989.8 |
| 2026-04-20 | 253,151 | $98.44 | $24.9M |
| 2026-04-17 | 225 | $96.92 | $21,807 |
| 2026-04-14 | 833 | $91.88 | $76,536.04 |
| 2026-04-09 | 2,074 | $89.82 | $186,286.68 |
| 2026-04-02 | 41 | $88.86 | $3,643.26 |
| 2026-03-23 | 882 | $85.06 | $75,022.92 |
| 2026-03-20 | 115 | $87.41 | $10,052.15 |
| 2026-03-19 | 1,077 | $87.01 | $93,709.77 |
| 2026-03-18 | 3,625 | $87.08 | $315,665 |
| 2026-03-17 | 13,896 | $82.97 | $1.2M |
| 2026-03-13 | 1,359 | $83.85 | $113,952.15 |
| 2026-03-11 | 19,775 | $84.60 | $1.7M |
| 2026-03-04 | 5 | $86.65 | $433.25 |
| 2026-03-03 | 2,432 | $85.98 | $209,103.36 |
| 2026-03-02 | 4,081 | $84.38 | $344,354.78 |
| 2026-02-27 | 96 | $85.86 | $8,242.56 |
| 2026-02-26 | 6,625 | $84.22 | $557,957.5 |
| 2026-02-25 | 2,759 | $82.84 | $228,555.56 |
| 2026-02-23 | 4,544 | $82.58 | $375,243.52 |
| 2026-02-13 | 148 | $84.45 | $12,498.6 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare LRN to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.